Why Aurora’s Latest CBD Play is a Big Deal
Despite being the most popular cannabis company in the world, particularly among millennials, Aurora Cannabis (NYSE: ACB) has yet to live up to its perceived potential, even given the nascent nature of the industry. There are many reasons for that, but perhaps the most important is Aurora's share dilution problem. While relying on dilutive forms of financing was a necessary evil for most pot companies in their early stages, Aurora did so at a dizzying pace, which is likely dragging down its stock price. Further, unlike many of it peers, Aurora has yet to land a big name partner. Such a partnership would allow the firm to have access to the cash it needs to fund its expensive growth projects. Despite these headwinds, Aurora is arguably one of the better investment options in the cannabis industry, and the company recently made an important move that improved its prospects.
Image source: Getty Images
Aurora completes the acquisition of Hempco
Source Fool.com
